An engineered gastrointestinally stable microbial leucine decarboxylase for potential treatment of maple syrup urine disease

Authors

Chinping Chng, Codexis, Inc.Follow
Kristen Skvorak, Codexis Inc.
Joyce Liu, Codexis Inc.
Nikki Kruse, Codexis Inc.
Roasa Mehmood, Codexis Inc.
Subhamoy Das, Codexis Inc.
Stephan Jenne, Codexis Inc.
U Loi Lao, Codexis Inc.
Da Duan, Codexis Inc.
Jonathan Asfaha, Codexis Inc.
Faye Du, Codexis Inc.
Leanne Teadt, Codexis Inc.
Charlene Ching, Codexis Inc.
Antoinette Sero, Codexis Inc.
James Riggins, Codexis Inc.
Lianne Pope, Codexis Inc.
Ping Yan, Codexis Inc.
Moulay Hicham Alaoui Ismaili, Codexis Inc.
Gjalt Huisman, Codexis Inc.
Kerryn McCluskie, Codexis Inc.
Adam Silverman, Codexis Inc.

Conference Dates

October 1-6, 2023

Abstract

Please click Additional Files below to see the full abstract

Recommended Citation

Chinping Chng, Kristen Skvorak, Joyce Liu, Nikki Kruse, Roasa Mehmood, Subhamoy Das, Stephan Jenne, U Loi Lao, Da Duan, Jonathan Asfaha, Faye Du, Leanne Teadt, Charlene Ching, Antoinette Sero, James Riggins, Lianne Pope, Ping Yan, Moulay Hicham Alaoui Ismaili, Gjalt Huisman, Kerryn McCluskie, and Adam Silverman, "An engineered gastrointestinally stable microbial leucine decarboxylase for potential treatment of maple syrup urine disease" in "Enzyme Engineering XXVII", Ang Ee Lui, Singapore Institute of Food and Biotechnology Innovation, A*STAR, Singapore; Yan Feng, Shanghai Jiao Tong University, China; Li Zhi, National University of Singapore, Singapore Eds, ECI Symposium Series, (2023). https://dc.engconfintl.org/enzyme_xxvii/85